News
-
HeSANDA Stakeholder Consultation
ACTA is working with the Australian Research Data Commons (ARDC) on a broad stakeholder consultation to gather insights and feedback about the Health Studies Australian…
-
Push to Make Clinical Trials More Diverse
The global race to find a safe COVID-19 vaccine has highlighted the need to include a diverse range of participants in clinical trials. In some…
-
National Clinical Trials Governance Framework Pilot: Update
Clinical Trials – Phase 2 Advisory Committee Communique – Meeting 4, 30 March 2021 This Communique provides an update on the Clinical Trials – Phase…
-
Investigator‐initiated trials run by CTNs provide net economic benefits to health systems
ACTA, in collaboration with the Australian Commission on Safety and Quality in Health Care (ACSQHC), has published an article in the Medical Journal of Australia…
-
Putting the “good” into Good Clinical Practice
Current Good Clinical Practice guidelines are bureaucratic and should align with less burdensome examples of international trial policy. ACTA congratulates Tanya Symons (University of Sydney),…
-
‘Consumers as researchers’ at CHF 2021 Summit
ACTA’s commitment to enhancing consumer involvement and engagement in clinical trials was the subject of presentations by ACTA Board members Anne McKenzie AM and Prof…
Search News
General search and filters
Filter by:
Topics
Results filtered by:
-
HeSANDA Stakeholder Consultation
-
Push to Make Clinical Trials More Diverse
-
ARCN virtual workshop
-
‘Consumers as researchers’ at CHF 2021 Summit
-
National Clinical Trials Governance Framework Pilot: Update
-
ACTA talks “Consumers as Researchers” at CHF Summit 2021
-
Deadline extended for ACTA Trial of the Year Award nominations!
-
Investigator‐initiated trials run by CTNs provide net economic benefits to health systems
-
Registrations of interest now open for the HeSANDA Infrastructure Development program
-
Grant Opportunity: MRFF Clinician Researchers Initiative
-
White Coats Foundation: First Power of One Grant Opportunity
-
Putting the “good” into Good Clinical Practice